Targeting CXCR4-induced desmoplasia to improve checkpoint inhibition in breast cancer
Author(s) -
George W. Sledge
Publication year - 2019
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1900368116
Subject(s) - medicine , breast cancer , cancer , oncology , metastatic breast cancer , atezolizumab , cancer research , triple negative breast cancer , lung cancer , targeted therapy , nivolumab , immunotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom